Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial.

Name: Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial.
Author: Wester, Ruth

Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial. — المؤلف: Wester, Ruth — Haematologica 20200713

المؤلف: Wester, Ruth
النشر: Haematologica 20200713
الوصف: 2265-2273 p.
الموضوعات: Adult؛ Aged؛ Antineoplastic Combined Chemotherapy Protocols؛ Biomarkers؛ Consolidation Chemotherapy؛ Dexamethasone؛ Female؛ Humans